Basics Vor Biopharma Inc. Common Stock IPO Date: February 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $274.1M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 4.58% Avg Daily Range (30 D): $0.66 | 5.65% Avg Daily Range (90 D): $0.93 | 5.04% Institutional Daily Volume Avg Daily Volume: 1.18M Avg Daily Volume (30 D): 2.35M Avg Daily Volume (90 D): 2.54M Trade Size Avg Trade Size (Sh.): 316 Avg Trade Size (Sh.) (30 D): 86 Avg Trade Size (Sh.) (90 D): 177 Institutional Trades Total Inst.Trades: 113 Avg Inst. Trade: $2.26M Avg Inst. Trade (30 D): $1.43M Avg Inst. Trade (90 D): $1.58M Avg Inst. Trade Volume: .03M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.19M Avg Closing Trade (30 D): $2.37M Avg Closing Trade (90 D): $1.8M Avg Closing Volume: 35.41K     News Nov 11, 2025 @ 2:56 AM Vor Bio Announces Pricing of Public Offering of $1... Source: Vor Biopharma Inc. Nov 8, 2025 @ 4:45 PM Telitacicept Achieved Primary Endpoint of Reducing... Source: Vor Bio Oct 31, 2025 @ 8:30 PM Vor Bio Reports Inducement Grants Under Nasdaq Lis... Source: Carl Mauch And Sarah Spencer Aug 18, 2025 @ 8:35 PM Vor Bio Reports Inducement Grants Under Nasdaq Lis... Source: Vor Bio Jun 25, 2025 @ 8:50 PM Vor Bio Announces $175 Million Private Placement Source: Sarah Spencer Financials   TTM Q3 2025 Q2 2025 Basic EPS $-110.92 $-121.63 $-12.56 Diluted EPS $-110.92 $-121.63 $-12.56 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -2449.55M $ -812.68M $ -1573.67M Operating Income / Loss $ -366.99M $ -28.11M $ -274.28M Cost of Revenue $ $ $ Net Cash Flow $ 105.42M $ -32.36M $ 140.53M PE Ratio     Splits Sep 19, 2025:   1:20